SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Lupus/Nephritis
An SI Board Since March 2001
Posts SubjectMarks Bans
95 18 0
Emcee:  keokalani'nui Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
70SCT for lupus makes jama. >>In the study of 50 people with lupus, patientkeokalani'nui-2/1/2006
692005: A Year of Accelerated Momentum for Lupus Research and Education Efforts WJohn McCarthy-12/28/2005
68Statement from Sandra C. Raymond, President and CEO of the Lupus Foundation of AJohn McCarthy-11/23/2005
67Research Published in The New England Journal of Medicine Challenges 30-Year- Olkeokalani'nui-11/23/2005
66MedImmune and Medarex Announce Filing of Investigational New Drug Application fokeokalani'nui-10/13/2005
65CYCLACEL ANNOUNCES COLLABORATION ON NEPHROLOGY APPLICATIONS OFkeokalani'nui-9/14/2005
64Dynavax / Oligonucleotide-based Inhibitors of Toll-Like Receptors -7, -8 and -9 nigel bates-1/10/2005
63Spontaneous Autoimmunity in 129 and C57BL/6 Mice—Implications for Autoimmunity Dnigel bates-9/6/2004
62ZymoGenetics Announces Start of TACI-Ig Clinical Study in Lupus Patients Tuesdaynigel bates-7/27/2004
61Transplant Drugs Seen as Better Alternatives to 'Gold Standard' Therapy nigel bates-3/4/2004
60Xencor Determines Structure of BAFF (BLyS), a Key Autoimmune Disease Target Disnigel bates-1/29/2004
59Yeah, you told me, long ago and having fooled me, that you weren't a scientiscaram(o)uche-1/13/2004
58Rick - no relation .... I'm just a smucky programmer ... regards, JohnJohn McCarthy-1/13/2004
57Dr. John McCarthy Joins Pharsight Corporation as Senior Scientist and Clinical Cscaram(o)uche-1/13/2004
56ZymoGenetics and Serono Initiate Clinical Trial with TACI-Ig Inhibitor of B-cellnigel bates-9/29/2003
55La Jolla Pharmaceutical Plans to Submit NDA for Riquent(TM) SAN DIEGO, May 5 /Pnigel bates-5/5/2003
54HGSI's LymphoStat-B to go into P II, and gets fast tracked: Message 18864358nigel bates-4/21/2003
532003 - [Lupus][Anticancer drug shows promise against lupus] Anticancer drug shoJohn McCarthy-3/13/2003
522/11/2003 -- A team of scientists supported by the National Institute of Arthritkeokalani'nui-2/11/2003
511/22/2003 -- Rapamycin, a drug approved for use in kidney transplant patients tonigel bates-1/22/2003
50ABGX/CRGN Mab. CuraGen and Abgenix Announce Progress in Antibody Alliance and Skeokalani'nui-1/9/2003
49HGSI--LymphoStat-B(TM) -- Enrollment Completed for Phase 1 Clinical Trial for Trkeokalani'nui-1/6/2003
48DeletedDavid Howe-12/23/2002
47ZGEN / TACI-Ig <i>ZymoGenetics Highlights Development Programs at Analystnigel bates-12/3/2002
46To say the FDA is bending over backwards would be an understatement. Yours is tkeokalani'nui-8/30/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News